A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : AAV / ANCA-associated vasculitis

[Related PubMed/MEDLINE]
Total Number of Papers: 685
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   AAV  (>> Co-occurring Abbreviation)
Long Form:   ANCA-associated vasculitis
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2021 A case of pulmonary arterial hypertension complicated by anti-neutrophil cytoplasmic antibody-associated vasculitis and systemic sclerosis. GC, MPO, PAH
2021 A proposed role of neutrophil extracellular traps and their interplay with fibroblasts in ANCA-associated vasculitis lung fibrosis. MPA, NETs
2021 A real-world assessment of mycophenolate mofetil for remission induction in eosinophilic granulomatosis with polyangiitis. EGPA, MMF
2021 A shared motif of hla-dpb1 affecting the susceptibility to pr3-anca positive granulomatosis with polyangiitis: comparative analysis of a Turkish cohort with matched healthy controls. ---
2021 Advances in the genomics of ANCA-associated vasculitis-a view from East Asia. ANCA, GWAS, MPA, MPO, PR3
2021 Altered circulating CCR6+and CXCR3+ T cell subsets are associated with poor renal prognosis in MPO-ANCA-associated vasculitis. MPO, PBMCs, PR3
2021 ANCA Testing in Clinical Practice: From Implementation to Quality Control and Harmonization. ANCA
2021 ANCA-associated renal vasculitis is associated with rurality but not seasonality or deprivation in a complete national cohort study. GPA, MPA
2021 ANCA-Associated Vasculitis Following Pfizer-BioNTech COVID-19 Vaccine. COVID-19, SARS-CoV-2
10  2021 ANCA-associated vasculitis overlaps with systemic sclerosis: a case report and literature review. ANCA, CRP, SRC, SSc
11  2021 ANCA-associated vasculitis with protein-losing enteropathy is characterized by hypocomplementemia. PLE
12  2021 Anti-Neutrophil Cytoplasmic Antibodies: To Care or Not to Care. ANA, ANCA
13  2021 Anti-neutrophil cytoplasmic antibody specificity determines a different clinical subset in granulomatosis with polyangiitis. ANCA, MPO-GPA, PR3-GPA
14  2021 Antibody subtypes and titers predict clinical outcomes in ANCA-associated vasculitis. ANCA, ESRD, MPO, PR3
15  2021 Antimyeloperoxidase and proteinase 3 antibodies for nephritis flare prediction in ANCA-associated-vasculitis. MPOab, PR3ab
16  2021 Antineutrophil Cytoplasmic Antibody-Associated Vasculitis With Acute Kidney Injury: Short-Term Recovery Predicts Long-Term Outcome. AKI, ANCA, ESRD, SCr
17  2021 Antiphospholipid Antibodies in Inflammatory and Autoimmune Rheumatic and Musculoskeletal Diseases Beyond Lupus: A Systematic Review of the Available Evidence. aPL, APS, RMDs, SLE, SSc
18  2021 Association of venous thromboembolic events with skin, pulmonary and kidney involvement in ANCA-associated vasculitis: a multinational study. ANCA, CIs, ORs, VTE
19  2021 Blood CD3-(CD56 or 16)+ natural killer cell distributions are heterogeneous in healthy adults and suppressed by azathioprine in patients with ANCA-associated vasculitides. EGPA, GPA, MPA, NK
20  2021 Characterisation of an enhanced preclinical model of experimental MPO-ANCA autoimmune vasculitis. ANCA, EAV, MPO, NTS
21  2021 Chemokine/Cytokine Levels Correlate with Organ Involvement in PR3-ANCA-Associated Vasculitis. BVAS, CCL, IL, MCP-2, SCF, TPO, TSLP
22  2021 Clinical significance of large unstained cell count in estimating the current activity of antineutrophil cytoplasmic antibody-associated vasculitis. ANCA, BVAS, LUC
23  2021 CMTM6-Deficient Monocytes in ANCA-Associated Vasculitis Fail to Present the Immune Checkpoint PD-L1. PD-L1
24  2021 Co-Occurrence of ANCA-Associated Vasculitis and Sjögren's Syndrome in a Patient With Acromegaly: A Case Report and Retrospective Single-Center Review of Acromegaly Patients. MPA, SS, WES
25  2021 Comparative efficacy and safety of rituximab, mycophenolate, and cyclophosphamide in active antineutrophil cytoplasmic antibody-associated vasculitis: A Bayesian network meta-analysis of randomized controlled trials. ANCA, CrI, CYC, MMF, SAEs, SUCRA
26  2021 Comparison of outcomes using the rituximab originator MabThera with the biosimilar Truxima in patients with ANCA-associated vasculitis. ANCA
27  2021 Complement Components C3 and C4 Indicate Vasculitis Manifestations to Distinct Renal Compartments in ANCA-Associated Glomerulonephritis. AKI, ANCA, CKD, ESRD, GN, MPO, PR3
28  2021 Correlation between serum cysteine-rich protein 61 and disease activity of antineutrophil cytoplasmic antibody-associated vasculitis. ANCA, BVAS, Cyr61, IL, NF-kappaB, RR
29  2021 Corticosteroids are the major contributors to the risk for serious infections in autoimmune disorders with severe renal involvement. CryoVasc, IS, LN
30  2021 Cyclophosphamide induction dose and outcomes in ANCA-associated vasculitis with renal involvement: A comparative cohort study. ---
31  2021 Developing a composite outcome tool to measure response to treatment in ANCA-associated vasculitis: A mixed methods study from OMERACT 2020. OMERACT
32  2021 Dose-dependent Pharmacological Response to Rituximab in the Treatment of Antineutrophil Cytoplasmic Antibody-associated Vasculitis. ANCA, RTX
33  2021 Efficacy of plasma exchange for antineutrophil cytoplasmic antibody-associated systemic vasculitis: a systematic review and meta-analysis. AEs, ANCA, CI, CR, EGPA, GPA, MPA, PE, RCTs, RR
34  2021 Endotrophin, a collagen type VI-derived matrikine, reflects the degree of renal fibrosis in patients with IgA nephropathy and in patients with ANCA-associated vasculitis. CKD, COL VI, ETP, IgAN
35  2021 Eosinophilic Granulomatosis with Polyangiitis: A Systematic Review and Meta-Analysis of Test Accuracy and Benefits and Harms of Common Treatments. ANCA, EGPA, GPA, MPA, MPO, PICO
36  2021 Fibrinogen to albumin ratio reflects the activity of antineutrophil cytoplasmic antibody-associated vasculitis. ANCA, BVAS, CRP, ESR, FAR
37  2021 First exposure to rituximab is associated to high rate of anti-drug antibodies in systemic lupus erythematosus but not in ANCA-associated vasculitis. ADAs, BVAS, ECL, SLE
38  2021 FRAX scores are increased in patients with ANCA-associated vasculitis. ---
39  2021 Granulomatosis with Polyangiitis: Recurrence or Treatment Consequences? ANCA, GPA
40  2021 Granulomatous Inflammation in ANCA-Associated Vasculitis. DAMP, EGPA, GPA, MPA, MPO, PR3
41  2021 Highly Sensitive Flow Cytometric Detection of Residual B-Cells After Rituximab in Anti-Neutrophil Cytoplasmic Antibodies-Associated Vasculitis Patients. ANCA, ASC, HSFC, MRA, PBMCs, PBs, PC, Pre-GC, RTX
42  2021 Hypertrophic Pachymeningitis in Eosinophilic Granulomatosis with Polyangiitis. ANCA, EGPA, HP
43  2021 Identification of neutrophil β2-integrin LFA-1 as a potential mechanistic biomarker in ANCA-associated vasculitis via microarray and validation analyses. ANCA, GSEA, HCs, HUVECs, ICAM-1, LFA-1
44  2021 IgG4-related disease and ANCA positive vasculitis in childhood: a case-based review. AIP, IgG4-RD
45  2021 Impact of interstitial lung disease on mortality in ANCA-associated vasculitis: A systematic literature review and meta-analysis. AAV-ILD, ILD, RR
46  2021 Incidence and clinical predictors of infections in patients treated with severe systemic ANCA-associated vasculitis. CCI, CYC
47  2021 Increased prevalence rate of metabolic syndrome is an independent predictor of cardiovascular disease in patients with antineutrophil cytoplasmic antibody-associated vasculitis. ANCA, BMI, BVAS, CVD, MetS
48  2021 Indications and diagnostic outcome of antineutrophil cytoplasmic antibody testing in hospital medicine: a pattern of over-screening. ANCA
49  2021 Lupus nephritis and ANCA-associated vasculitis: towards precision medicine? ANCA, LN, PR3
50  2021 Lymphopenia at diagnosis of ANCA-vasculitis with renal involvement is correlated with severity and renal prognosis. AAV-RI, ESKD
51  2021 Managing ANCA-associated vasculitis during the COVID-19 pandemic: results from an online survey. CYC, MMF
52  2021 Microscopic Polyangiitis Presenting with Splenic Infarction: A Case Report. ANCA, CT, MPA
53  2021 Monomeric C-reactive protein promotes platelets to release mitochondrial DNA in anti-neutrophil cytoplasmic antibody-associated vasculitis. ANCA, mCRP, mtDNA, pCRP, TLR9
54  2021 Mortality and cause of death in patients with AAV/PAN in Australia-a population-based study. ANCA, CI, HR, IHD, PAN, SMR, WA
55  2021 New insights into the epidemiology of ANCA-associated vasculitides in Germany: results from a claims data study. GPA, MPA
56  2021 Novel mortality-predicting index at diagnosis can effectively predict all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis. ANCA, CAR, IPI, MPI, NLR
57  2021 Overlap syndrome SLE - ANCA associated vasculitis. SLE
58  2021 Platelet CXCL4 mediates neutrophil extracellular traps formation in ANCA-associated vasculitis. HCs, NETs, TLR
59  2021 Pleuritis and Pericarditis in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis. ANCA, EGPA, GPA, MPA
60  2021 Predicting relapse in anti-neutrophil cytoplasmic antibody-associated vasculitis: a Systematic review and meta-analysis. HRs
61  2021 Prevalence and risk factors of relapse in patients with ANCA-associated vasculitis receiving cyclophosphamide induction: a systematic review and meta-analysis of large observational studies. aHRs, CIs, CRRs, PR3
62  2021 Prevalence of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and Spatial Association With Quarries in a Region of Northeastern France: A Capture-Recapture and Geospatial Analysis. ANCA, GPA, GWR, MPA, RLV
63  2021 Pulmonary Involvement in Primary Systemic Vasculitides. DCVAS, EGPA, GCA, GPA, IgAV, MPA, PAN, TAK, VDI
64  2021 Pulmonary Low Attenuation Areas on CT in ANCA-associated Vasculitis: A quantitative and semi-quantitative analysis correlated with pulmonary function testing for obstructive airway disease. LAA
65  2021 Reappraisal of Renal Arteritis in ANCA-associated Vasculitis: Clinical Characteristics, Pathology, and Outcome. C-index
66  2021 Renal and overall outcomes of double-positive (ANCA and anti-GBM antibodies) patients compared to ANCA-associated vasculitis patients with severe renal involvement: A multicenter retrospective study with systematic renal pathology analysis. ANCAs, DPPs, GBM
67  2021 Reply. MPA
68  2021 Rheumatoid factor positivity in antineutrophil cytoplasmic antibody-associated vasculitis: a distinct clinical entity or innocent bystander? ANCA, PSM, RF
69  2021 Rituximab Associated Hypogammaglobulinemia in Autoimmune Disease. ANCA, CI, IgG, OR, RTX, SLE
70  2021 Rituximab-associated hypogammaglobulinemia in autoimmune rheumatic diseases: a single-center retrospective cohort study. AIRD, CTD, RA, RTX
71  2021 Serious infections in ANCA-associated vasculitides in the biologic era: real-life data from a multicenter cohort of 162 patients. CYC, GPA, MPA, SI
72  2021 Serum chitinase-3-like 1 protein is a useful biomarker to assess disease activity in ANCA-associated vasculitis: an observational study. AAGN, ANCA, BVAS, FFS, SF-36
73  2021 Severe cutaneous presentation of hydralazine-induced ANCA vasculitis without renal or pulmonary involvement, complicated by DIC. ANCA
74  2021 Severe infections in patients with ANCA associated vasculitis treated with rituximab. RTX
75  2021 Should PLEX Be Used for Severe AKI and/or Pulmonary Hemorrhage in ANCA-Associated Vasculitis (AAV)? PRO. ---
76  2021 Significance of antineutrophil cytoplasmic antibody positivity in patients with systemic sclerosis: a single-centre pilot study in Korea. ANCA, MPA, SSc
77  2021 The biology, pathogenetic role, clinical implications, and open issues of serum anti-neutrophil cytoplasmic antibodies. ANCA, MPO, PR3
78  2021 The Nasal Microbiome in ANCA-Associated Vasculitis: Picking the Nose for Clues on Disease Pathogenesis. ---
79  2021 The Role of Mycophenolate Mofetil for the Induction of Remission in ANCA-Associated Vasculitis: A Meta-Analysis. CYC, MMF
80  2021 The role of trimethoprim/sulfametoxazole in reducing relapses and risk of infections in ANCA-associated vasculitis: a meta-analysis. GPA, RCTs, RRs, TMP/SMX
81  2021 The significance of metalloproteinase 3 (MMP-3), chemokine CXC ligand 13 (CXCL-13) and complement component C5a in different stages of ANCA associated vasculitis. C5a, CXCL13, ROC
82  2021 The therapeutic effect of plasma exchange on ANCA-associated vasculitis: A meta-analysis. ANCA, CI, ESRD, OR, PLEX, RCTs
83  2021 Therapy of ocular complications in ANCA+ associated vasculitis. ANCA
84  2021 Topic modeling to characterize the natural history of ANCA-Associated vasculitis from clinical notes: A proof of concept study. EHR
85  2021 Tubulointerstitial nephritis in antineutrophil cytoplasmic antibody-associated vasculitis with monoclonal gammopathy. ANCA, CRP, TIN
86  2021 Two Cases of Vasculitis with Renal Vein Thrombosis. MPO, PR3
87  2021 Unclassifiable repeated antineutrophil cytoplasmic antibody (ANCA) positivity in diseases other than ANCA-associated vasculitis. ANCA
88  2021 Update in the Management of ANCA-Associated Vasculitis: Recent Developments and Future Perspectives. ---
89  2021 Use of Rituximab for the Treatment of Antineutrophil Cytoplasm Antibody-associated Vasculitis in Canada, 2010-2020. ANCA, CanVasc, GPA, MPA, RTX
90  2021 Usefulness of tissue inhibitor of metalloproteinase 1 as a predictor of sustained remission in patients with antineutrophil cytoplasmic antibody-associated vasculitis. ANCA, GPA, MPA, TIMP-1
91  2021 Validation of the provisional seven-item criteria for the diagnosis of polyarteritis nodosa. ACR, ANCA, DADA2, MHLW, PAN
92  2021 Venous thromboembolism in ANCA-associated vasculitis: a population-based cohort study. BVAS, CI, SIR, VTE
93  2021 [ANCA vasculitis preceded by isolated joint manifestations. Report of two cases and literature review]. ANCA
94  2020 A case of ANCA associated vasculitis in a patient presenting with chest pain. ANCA, CT
95  2020 A Case of Diffuse Alveolar Hemorrhage Associated with High-Titer of MPO-ANCA Demonstrating Cytoplasmic Staining Pattern. DAH, IIF, MPO, PR3
96  2020 A Case of Granulomatosis with Polyangiitis: Consequences of Delayed Diagnosis in a Life-threatening Malady. ANCA, GPA
97  2020 A case of vasculitis case with unusual renal pathological findings presenting with rapidly progressing renal failure. ---
98  2020 A retrospective study on the epidemiology of ANCA-associated vasculitis in two Australian health districts. CI, ISLHD, SESLHD
99  2020 A unique case of ovarian manifestation of systemic vasculitis that mimics ovarian cancer. ANCA, GPA
100  2020 Abdominal Pain, an Atypical Presenting Symptom of Granulomatosis with Polyangiitis. ANCA, GPA